Healthcare provider profile · identity verified

Veronica Santee, MD

Family Practice · GROVE CITY, PA · NPI 1447283759

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	506	137
Levothyroxine Sodium	Levothyroxine Sodium	457	107
Amlodipine Besylate	Amlodipine Besylate	366	91
Pantoprazole Sodium	Pantoprazole Sodium	234	62
Omeprazole	Omeprazole	218	51
Metformin Hcl	Metformin Hcl	192	53
Lisinopril	Lisinopril	190	52
Potassium Chloride	Potassium Chloride	189	48
Losartan Potassium	Losartan Potassium	181	44
Pravastatin Sodium	Pravastatin Sodium	168	41
Albuterol Sulfate Hfa	Albuterol Sulfate	143	32
Metoprolol Tartrate	Metoprolol Tartrate	136	31
Metformin Hcl Er	Metformin Hcl	134	35
Clopidogrel	Clopidogrel Bisulfate	132	31
Metoprolol Succinate	Metoprolol Succinate	130	33
Gabapentin	Gabapentin	128	30
Sertraline Hcl	Sertraline Hcl	126	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	19
Furosemide	Furosemide	108	28
Rosuvastatin Calcium	Rosuvastatin Calcium	103	29
Tamsulosin Hcl	Tamsulosin Hcl	103	25
Tramadol Hcl	Tramadol Hcl	98	17
Ozempic	Semaglutide	91	20
Simvastatin	Simvastatin	91	24
Lorazepam	Lorazepam	90	24
Eliquis	Apixaban	89	19
Carvedilol	Carvedilol	88	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	88	21
Hydrochlorothiazide	Hydrochlorothiazide	86	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	16
Glipizide	Glipizide	84	21
Escitalopram Oxalate	Escitalopram Oxalate	82	20
Zolpidem Tartrate	Zolpidem Tartrate	82	19
Synthroid	Levothyroxine Sodium	75	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	11
Alendronate Sodium	Alendronate Sodium	69	20
Montelukast Sodium	Montelukast Sodium	67	suppressed
Trazodone Hcl	Trazodone Hcl	65	12
Tizanidine Hcl	Tizanidine Hcl	54	suppressed
Trulicity	Dulaglutide	54	11
Citalopram Hbr	Citalopram Hydrobromide	53	14
Famotidine	Famotidine	53	13
Pioglitazone Hcl	Pioglitazone Hcl	53	15
Farxiga	Dapagliflozin Propanediol	52	13
Allopurinol	Allopurinol	50	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Valsartan	Valsartan	49	12
Atenolol	Atenolol	47	12
Ibuprofen	Ibuprofen	47	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	47	20
Mounjaro	Tirzepatide	46	suppressed
Celecoxib	Celecoxib	45	suppressed
Ondansetron Odt	Ondansetron	45	15
Alprazolam	Alprazolam	44	12
Duloxetine Hcl	Duloxetine Hcl	43	12
Januvia	Sitagliptin Phosphate	39	suppressed
Prednisone	Prednisone	39	29
Topiramate	Topiramate	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Pregabalin	Pregabalin	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	13
Glipizide Er	Glipizide	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Ketoconazole	Ketoconazole	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Verapamil Er	Verapamil Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Mupirocin	Mupirocin	17	13
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ramipril	Ramipril	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Finasteride	Finasteride	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Indapamide	Indapamide	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error